🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested
Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Status
Terminated
Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Start Date
2003-11
Trial ID
NCT00670410
Treatments Being Tested
The goal of this clinical research study is to learn if giving romidepsin b...
Status
Completed
Location
The Ohio State University Cancer Center
Start Date
2017-12-08
Trial ID
NCT02512497
Treatments Being Tested
Phase II trial to study the effectiveness of combination chemotherapy and p...
Status
Terminated
Location
Gynecologic Oncology Group
Start Date
1999-11
Trial ID
NCT00004221
RATIONALE: Bortezomib and thalidomide may stop the growth of multiple myelo...
Status
Completed
Location
City of Hope Medical Center
Start Date
2008-01-16
Trial ID
NCT00792142
ACLF is a syndrome characterized by rapid deterioration of liver function i...
Status
Unknown
Location
Renji Hospital, Shanghai Jiao Tong University, School of Medicine
Start Date
2023-10-15
Trial ID
NCT06069037
Treatments Being Tested
The study was set up to assess: 1. Standard-dose versus high-dose remissio...
Status
Completed
Location
Dipartimento di Ematologia e Medicina Trasfusionale - Azienda Osp. Nazionale Santi Antonio e Biagio e Cesare Arrigo
Start Date
2006-11
Trial ID
NCT00495287
Treatments Being Tested
This phase I/II trial studies the safety, side effects, and best dose of de...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-09-23
Trial ID
NCT06928662
Hypothesis : pegfilgrastim at 200 µg/kg between 12 and 18 days after previo...
Status
Unknown
Location
CHU
Start Date
TBD
Trial ID
NCT00751894
Treatments Being Tested
This is a randomised, open-label, multicenter, phase III study for adult de...
Status
Active Not Recruiting
Location
Area Vasta N. 5 Ascoli Piceno - S. Benedetto Del Tronto, Presidio Ospedaliero Av5 Osp. Gen. Prov.Le "C.G.Mazzoni" - Uoc Ematologia
Start Date
2021-09-08
Trial ID
NCT04722848
Treatments Being Tested